Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05725499

The Effect of Transcutaneous Stimulation on Blood Pressure in Spinal Cord Injury (SCI)

This project will investigate the effect of spinal cord transcutaneous stimulation on blood pressure in individuals with a chronic spinal cord injury who experience blood pressure instability, specifically, orthostatic hypotension (a drop in blood pressure when moving from lying flat on your back to an upright position).

The main questions it aims to answer are:

1. What are the various spinal sites and stimulation parameters that normalize and stabilize blood pressure during an orthostatic provocation (70 degrees tilt)? 2. Does training, i.e., exposure to repeated stimulation sessions, have an effect on blood pressure stability?

Participants will undergo orthostatic tests (lying on a table that starts out flat, then tilts upward up to 70 degrees), with and without stimulation, and changes in their blood pressure will be evaluated.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Kessler Foundation

West Orange, New Jersey, 07052, United States

Location status: Recruiting

Location contact

Einat Engel-Haber, MD

CONTACT

[email protected]

Einat Engel-Haber, MD

SUB_INVESTIGATOR

Gail F Forrest, PhD

PRINCIPAL_INVESTIGATOR

LeighAnn Martinez, BA

CONTACT

[email protected]

973-324-3557

Steven Kirshblum, MD

SUB_INVESTIGATOR

About this study

Cardiovascular (CV) control in persons with a high level (thoracic level T6 or above) spinal cord injury (SCI) is often impaired, resulting in short and long-term health complications and a decline in quality of life. Orthostatic hypotension (OH), a significant decrease in blood pressure (BP) when moving from lying flat (supine) to an upright position, appears early after injury and is frequently accompanied by dizziness, weakness, fatigue, and even syncope. In the long term, while symptoms are typically diminished, it still clinically occurs in 50% of individuals with a cervical injury. The physical, social, and emotional consequences of OH pose a major issue. Moreover, BP instability is associated with a decline in CV health and somewhat accounts for the 3 to 4-fold increased risk for stroke and heart disease in this clinical population.

In recent years, epidural spinal cord stimulation has been explored with promising results as a potential treatment for CV dysfunction. Spinal cord transcutaneous stimulation (scTS) represents an alternate approach, with the potential to benefit more people with fewer risks. Only one study thus far successfully applied scTS to restore CV function and resolve orthostatic symptoms following SCI, with stimulation applied at one thoracic location.

The objective of this study is to investigate the effect of scTS on BP in individuals with chronic SCI who experience OH. Stimulation sites and parameters that consistently increase and stabilize systolic BP within the range of 110-120 mmHg, during an orthostatic provocation (a 70° tilt-test), will be sought. The investigators will also evaluate whether there is any change in the BP response following repeated stimulation sessions. This project will provide the foundational evidence to use scTS to improve autonomic function in various SCI populations and help overcome barriers to engagement in activity and participation imposed by autonomic dysfunction.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Spinal cord injury for greater than or equal to 6 months
  • Injury level ≥ T6 (thoracic level)
  • American Spinal Injury Association (ASIA) Impairment Scale (AIS) A-D
  • Exhibits at least one of the following hypotensive symptoms:
  • Baseline hypotension - resting supine or seated systolic blood pressure(SBP) < 90mmHg;
  • SBP drop ≥ 20 mmHg within 5 minutes of assuming seated position;
  • Symptoms of orthostasis with a drop of SBP (<90mmHg) from supine to sitting

Exclusion criteria

  • Current illness (infection, a pressure injury that might interfere with the intervention, a recent diagnosis of DVT/PE, etc.)
  • Ventilator-dependent
  • History of implanted brain/spine/nerve stimulators
  • Cardiac pacemaker/defibrillator or intra-cardiac lines
  • Significant coronary artery or cardiac conduction disease, a recent history of myocardial infarction
  • Insufficient mental capacity to understand and independently provide consent
  • Pregnancy
  • Cancer
  • Deemed unsuitable by study physician

Treatment and study plan

Biostim-5 transcutaneous spinal stimulator

Device

Transcutaneous stimulation of the spinal cord. Mapping will be performed to determine sites for optimal modulation of blood pressure. During each mapping day, with participants in a supine or seated position, electrodes will be placed on the midline of one of the following spinous processes: C5/6, T7/8, T11/12, L1/2 and S1/2. Stimulation intensity will start at 5 mA and gradually increased in 5 mA increments up to 100 mA. The frequency will be 2 or 30 Hz. Profiles will be established to guide selection of optimal site locations for blood pressure modulation. The profile chosen will be used during training and testing.

During testing, stimulation will be applied using the selected profile in order to normalize SBP to the range of 110-120 mmHg and stabilize it within this range during a 30-min tilt test.

On each session during the 2-week training-period, stimulation will be applied for 30 minutes using the selected profile, while the participant remains in a seated position.

Tilt-table orthostatic stress testing

Diagnostic Test

While lying supine, participants will be strapped to a Hi-Low tilt-table bed. The bed will gradually be tilted to a 70 degrees tilt, during which time continuous hemodynamic measures will be recorded. This position will be maintained for 30 minutes.

During some of the sessions, the tilt test will be accompanied by spinal stimulation.

Primary outcomes

  1. Optimal stimulation sites

    Time frame: Through Mapping and testing sessions, average of 3 weeks

    Identify scTS spinal segments that restore systolic BP within the normotensive range (110-120 mmHg).

  2. Optimal stimulation frequency

    Time frame: Through Mapping and testing sessions, average of 3 weeks

    Identify scTS frequency that restores systolic BP within the normotensive range (110-120 mmHg).

  3. Systolic blood pressure - efficacy of stimulation

    Time frame: Throughout the experiment, average of 6 weeks

    Evaluate changes in blood pressure during an orthostatic test (comparing measurements obtained during stimulation to those obtained without).

    The ability of scTS to normalize SBP (to the range of 110-120) and to stabilize it over the course of a 30-min tilt test will be assessed.

  4. Systolic blood pressure - effect of training

    Time frame: Post training, average of 2 weeks

    Explore the blood pressure response to orthostatic stress with and without stimulation, following six days of repetitive 30-min customized scTS sessions

  5. Orthostatic symptoms questionnaire

    Time frame: Throughout the experiment, average of 6 weeks

    A questionnaire ranking the severity of orthostatic symptoms (dizziness, nausea), with a scale of 1-10 (10 being the most severe).

Secondary outcomes

  1. EMG of leg muscles - muscle activation (analysis of mean and peak amplitudes)

    Time frame: Through Mapping and testing sessions, average of 3 weeks

    Analysis of leg-muscle EMG to identify configurations that modulate BP without eliciting motor activity, to ensure that BP response was not due to lower limb muscle contraction.

  2. Spinal Cord Injury-Quality of Life (SCI-QOL) questionnaires

    Time frame: Before the first session and after the last session, average of 6 weeks

    Accessible through computer adaptive testing and addresses the following domains: emotional health, physical-medical health, social participation, and physical function

  3. Global response assessment (GRA)

    Time frame: post training, average of 6 weeks

    GRA will be used to evaluate patients' perceptions of treatment effectiveness

  4. Additional hemodynamic measure - diastolic blood pressure

    Time frame: throughout the trial, average of 6 weeks

    Hemodynamic measures will be collected throughout the trial

  5. Additional hemodynamic measure - heart rate

    Time frame: throughout the trial, average of 6 weeks

    Hemodynamic measures will be collected throughout the trial

Study contacts

Contact information is provided by the study sponsor or research team.

Einat Engel-Haber, MD

CONTACT

[email protected]

LeighAnn Martinez, BA

CONTACT

[email protected]

(973)324-3557

Sponsors and collaborators

Lead sponsor

Kessler Foundation

Other

Registry information

Official study title

Neuromodulation of Blood Pressure Using Transcutaneous Spinal Stimulation in Chronic Spinal Cord Injury

Acronym: SCI

Important dates

Study start
2023
Primary completion
2026
Study completion
2026
First posted
Feb 13, 2023
Registry last updated
Sep 2, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.